# Effectiveness of Paclitaxel-coated Luminor® Balloon Catheter Versus Uncoated Balloon Catheter in the Arteria Femoralis Superficialis

Study · id `cardio:ct-nct02540018` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02540018](<https://clinicaltrials.gov/study/NCT02540018>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02540018

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 172 participants.

## Technical summary

Registry record NCT02540018. Randomized; single masking; primary purpose treatment. Start 2015-09-15 (actual); primary completion 2016-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 172 participants (planned count; ClinicalTrials.gov record NCT02540018, source copy `cardio:ctgov-nct02540018-2023-03-13`, retrieved 2026-10-31)
- Started: 2015-09-15 (actual) (ClinicalTrials.gov record NCT02540018, source copy `cardio:ctgov-nct02540018-2023-03-13`, retrieved 2026-10-31)
- Primary completion: 2016-12 (actual) (ClinicalTrials.gov record NCT02540018, source copy `cardio:ctgov-nct02540018-2023-03-13`, retrieved 2026-10-31)
- Completion: 2022-01-14 (actual) (ClinicalTrials.gov record NCT02540018, source copy `cardio:ctgov-nct02540018-2023-03-13`, retrieved 2026-10-31)
- Countries: Germany (ClinicalTrials.gov record NCT02540018, source copy `cardio:ctgov-nct02540018-2023-03-13`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02540018-2023-03-13`, retrieved 2026-10-31)

## The registry's words

- Brief title: Effectiveness of Paclitaxel-coated Luminor® Balloon Catheter Versus Uncoated Balloon Catheter in the Arteria Femoralis Superficialis
- Acronym: EffPac
- Condition: Peripheral Arterial Disease
- Intervention (Device): Transluminal Angioplasty with Paclitaxel-coated Luminor® Balloon Catheter in the Superficial Femoral and Popliteal Arteries
- Intervention (Device): Transluminal Angioplasty with and non-coated (CE-marked) plain old angioplasty balloon (POBA) catheter
- Lead sponsor: Jena University Hospital
- Lead sponsor class: OTHER
- Collaborator: iVascular S.L.U.
- Collaborator class: INDUSTRY
- Collaborator: KKS Netzwerk
- Collaborator class: NETWORK

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Jena University Hospital (`cardio:org-jena-university-hospital`)
- Registry lists this organization as a collaborator: iVascular S.L.U. (`cardio:org-ivascular-s-l-u`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial (`cardio:pubmed-31687933`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial (`cardio:pubmed-36088609`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e7c6ff1e7a6fcfe34e1ea06123c0a4fd26bd7c0dc59f8d82b040fb413a75a4de
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
